Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme. (2020)

First Author: Gawley M
Attributed to:  Engaging and creating “Influencers” within an academic-industry environment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2020.05.012

PubMed Identifier: 32407745

Publication URI: http://europepmc.org/abstract/MED/32407745

Type: Journal Article/Review

Volume: 324

Parent Publication: Journal of controlled release : official journal of the Controlled Release Society

ISSN: 0168-3659